The Ceftriaxone Sodium, cataloged under National Stock Number 6505-01-221-0311, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 8 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-221-0311 |
| Primary Part Number | NDC00781-3207-95 |
| Item Name | Ceftriaxone Sodium |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Inc. |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR AND INTRAVENOUS |
| Primary Container Content Quantity | 500.000 MILLIGRAMS OF ACTIVE INGREDIENT |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS CEFTRIAXONE EQUIVALENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00781-3207-95 PRIMARY | Sandoz Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00409-7338-20 | 5/2 Secondary reference U.S. Government activity |
| NDC00409-7338-01 | 3/9 Design control — primary reference Hospira, Inc. |
NSN 6505-01-221-0311 is a Ceftriaxone Sodium, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-221-0311 has 1 manufacturer part number on file: NDC00781-3207-95 (Sandoz Inc.).
Key specifications for NDC00781-3207-95: Administration: INTRAMUSCULAR AND INTRAVENOUS; Primary Container Content Quantity: 500.000 MILLIGRAMS OF ACTIVE INGREDIENT; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 8 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.